SCHEMBL22656555

SCHEMBL22656555

NC12CC(COc3ccccc3)(C1)C2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.42
KCNA3 P22001 1/20 0.41
ALDH1A1 P00352 1/20 0.38
RECQL P46063 1/20 0.38
SCN4A P35499 2/20 0.37
LTA4H P09960 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
PLA2G2A P14555 1/20 0.37
AOC3 Q16853 1/20 0.37
ALOX15 P16050 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAOA P21397 1/20 0.35
PTGS1 P23219 1/20 0.35
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23150117 0.77 KCNA3 (0.39) TAAR1KCNA3ALDH1A1RECQLTDP1
SCHEMBL24168827 0.76 KDM4E (0.48) ALDH1A1LTA4HAOC3
SCHEMBL1824875 0.75 MAOA (0.48) TAAR1KCNA3ALDH1A1RECQLSCN4A
SCHEMBL4205437 0.72 TAAR1 (0.42) TAAR1KCNA3ALDH1A1RECQLSCN4A
SCHEMBL22397098 0.72 ALOX15 (0.42) ALOX15NPC1RAB9ASMN1; SMN2
SCHEMBL3227805 0.71 MEN1 (0.41) TAAR1KCNA3ALDH1A1RECQLLTA4H
SCHEMBL16628135 0.71 DHFR (0.46) KCNA3TDP1
SCHEMBL3515342 0.71 TAAR1 (0.41) TAAR1KCNA3ALDH1A1RECQLSCN4A
SCHEMBL12453902 0.68 TAAR1 (0.47) TAAR1KCNA3ALDH1A1RECQLSCN4A
SCHEMBL24780612 0.67 KCNA3 (0.44) TAAR1KCNA3ALDH1A1RECQLLTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3704094-B1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2026-03-11 EP disclosed
US-20240166652-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2024-05-23 US disclosed
US-20200361941-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2020-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200361941-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 TAAR1 2815/4885KCNA3 4760/4885ALDH1A1 3433/4885
US-20240166652-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 TAAR1 2815/4885KCNA3 4760/4885ALDH1A1 3433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.